Credit Suisse’s VanEck Pharmaceutical ETF PPH Stock Holding History

Credit Suisse’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,290	Closed	-$566K	–	3237
2023 Q1	$566K	Hold	7,290	–	–	﹤0.01%	2684
2022 Q4	$567K	Buy	+7,290	New	+$538K	﹤0.01%	2706
2022 Q2	–	Sell	-6,323	Closed	-$504K	–	4220
2022 Q1	$504K	Buy	+6,323	New	+$484K	﹤0.01%	2968
2020 Q1	–	Sell	-1,133,000	Closed	-$72.7M	–	4183
2019 Q4	$72.7M	Buy	+1,133,000	New	+$68.3M	0.05%	391
2016 Q3	–	Sell	-51,722	Closed	-$3.03M	–	4219
2016 Q2	$3.03M	Buy	51,722 +20,284	+65%	+$1.18M	﹤0.01%	2022
2016 Q1	$1.81M	Buy	31,438 +27,092	+623%	+$1.6M	﹤0.01%	2276
2015 Q4	$284K	Sell	4,346 -72,460	-94%	-$4.68M	﹤0.01%	3705
2015 Q3	$4.84M	Buy	76,806 +69,576	+962%	+$4.89M	0.01%	1591
2015 Q2	$512K	Sell	7,230 -9,688	-57%	-$698K	﹤0.01%	3705
2015 Q1	$1.19M	Sell	16,918 -30,073	-64%	-$2.04M	﹤0.01%	2830
2014 Q4	$3.02M	Buy	46,991 +34,897	+289%	+$2.22M	﹤0.01%	2185
2014 Q3	$769K	Sell	12,094 -6,243	-34%	-$387K	﹤0.01%	3290
2014 Q2	$1.14M	Sell	18,337 -18,912	-51%	-$1.12M	﹤0.01%	3167
2014 Q1	$2.17M	Sell	37,249 -622	-2%	-$35.2K	﹤0.01%	2448
2013 Q4	$2.01M	Sell	37,871 -119,114	-76%	-$6.03M	﹤0.01%	2635
2013 Q3	$7.51M	Buy	156,985 +76,911	+96%	+$3.65M	0.01%	1326
2013 Q2	$3.64M	Buy	+80,074	New	+$3.7M	﹤0.01%	1837

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Credit Suisse's PPH Position: Q2 2023 in Review

Credit Suisse sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2023, closing a stake of 7,290 shares — an estimated $566K sold.

Credit Suisse first reported a position in PPH in Q2 2013 and held it in 17 quarters. The position peaked at $72.7M in Q4 2019. 102 funds tracked by Wall St. Rank hold PPH as of Q2 2023.

Credit Suisse reported no remaining VanEck Pharmaceutical ETF position as of Q2 2023 after selling out during the quarter.
Credit Suisse sold 7,290 VanEck Pharmaceutical ETF shares in Q2 2023, an estimated $566K.
Credit Suisse first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 17 quarters.
Credit Suisse's VanEck Pharmaceutical ETF position peaked at $72.7M in Q4 2019.
102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.